| Serial Number | 90747075 |
| Word Mark | EIKONIZO THERAPEUTICS |
| Filing Date | Tuesday, June 1, 2021 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 14, 2024 |
| Goods and Services | (Based on Intent to Use) Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; diagnostic agents, preparations, substances and diagnostic materials in the form of preparations for medical purposes; imaging agents for positron emission tomography (PET) imaging for delivery of materials to target sites within the body for diagnostic purposes; imaging agents for positron emission tomography (PET) imaging for use in detecting disease, namely, radio tracers for positron emission tomography (PET) imaging |
| Translation of Words in Mark | The English translation of "EIKONIZO" in the mark is "ENVISAGE". |
| Goods and Services | (Based on Use in Commerce) Providing a website featuring information in the field of treatment for medical conditions |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | (Based on Use in Commerce) Research and development in the field of drug discovery, imaging agents, biotechnology and pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 25, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 25, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, April 30, 2017 |
| First Use In Commerce Date | Sunday, April 30, 2017 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 1, 0001 |
| Primary Code | 044 |
| First Use Anywhere Date | Sunday, April 30, 2017 |
| First Use In Commerce Date | Sunday, April 30, 2017 |
| Party Name | Eikonizo Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Eikonizo Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Wednesday, August 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 15, 2022 | ASSIGNED TO EXAMINER |
| Friday, February 25, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, February 25, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, February 25, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 25, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 5, 2022 | ASSIGNED TO LIE |
| Thursday, October 6, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 6, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 26, 2022 | FINAL REFUSAL WRITTEN |
| Wednesday, October 26, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, October 26, 2022 | FINAL REFUSAL E-MAILED |
| Wednesday, April 26, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, April 26, 2023 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, April 26, 2023 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Wednesday, April 26, 2023 | EX PARTE APPEAL-INSTITUTED |
| Thursday, April 27, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 27, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 10, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, April 11, 2024 | EXPARTE APPEAL TERMINATED |
| Wednesday, April 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 14, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 14, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |